Actively Recruiting
The Norwegian Immunotherapy in Multiple Myeloma Study
Led by St. Olavs Hospital · Updated on 2025-03-03
400
Participants Needed
23
Research Sites
671 weeks
Total Duration
On this page
Sponsors
S
St. Olavs Hospital
Lead Sponsor
N
Norwegian University of Science and Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to study the effectiveness and complications of novel immunotherapies used in the treatment of multiple myeloma in routine care in Norway. The aim is to close knowledge gaps, generate evidence for future clinical trials and contribute to future consensus on how to monitor for adverse events, and what mitigation strategies should be implemented, so that we can increase patient survival and quality-of-life.
CONDITIONS
Official Title
The Norwegian Immunotherapy in Multiple Myeloma Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants age 60; 18 years
- Prior diagnosis of multiple myeloma as defined by IMWG criteria
- Prior diagnosis of primary plasma cell leukemia as defined by IMWG consensus definition
- Prior diagnosis of AL-amyloidosis as defined by IMWG criteria
- Planned treatment with Teclistamab (Tecvayli) outside clinical trials
- Planned treatment with Elranatamab (Elrexfio) outside clinical trials
- Planned treatment with Talquetamab (Talvey) outside clinical trials
- Planned treatment with Idecabtagene vicleucel (ide-cel/Abecma) outside clinical trials
- Planned treatment with Ciltacabtagene autoleucel (cilta-cel/Carvykti) outside clinical trials
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 23 locations
1
Sørlandet Hospital - Arendal
Arendal, Norway
Not Yet Recruiting
2
Ålesund hospital, Department of hematology
Ålesund, Norway
Not Yet Recruiting
3
Haukeland University Hospital
Bergen, Norway
Not Yet Recruiting
4
Bodø Hospital
Bodø, Norway
Not Yet Recruiting
5
Bærum Hospital
Bærum, Norway
Not Yet Recruiting
6
Drammen hospital
Drammen, Norway
Not Yet Recruiting
7
Førde hospital
Førde, Norway
Not Yet Recruiting
8
Innlandet hospital trust
Gjøvik, Norway
Not Yet Recruiting
9
Haugesund hospital
Haugesund, Norway
Not Yet Recruiting
10
Sørlandet hospital
Kristiansand, Norway
Not Yet Recruiting
11
Nordmøre and Romsdal Hospital - Kristiansund
Kristiansund, Norway
Not Yet Recruiting
12
Levanger hospital
Levanger, Norway
Not Yet Recruiting
13
Nordmøre and Romsdal Hospital - Molde
Molde, Norway
Not Yet Recruiting
14
Akershus University Hospital (AHUS)
Nordbyhagen, Norway
Not Yet Recruiting
15
Diakonhjemmet hospital
Oslo, Norway
Not Yet Recruiting
16
Lovisenberg Diaconal Hospital
Oslo, Norway
Not Yet Recruiting
17
Oslo Myeloma Center, Oslo University Hospital
Oslo, Norway
Not Yet Recruiting
18
Telemark Hospital Trust
Skien, Norway
Not Yet Recruiting
19
Stavanger University hospital
Stavanger, Norway
Not Yet Recruiting
20
University hospital of North Norway
Tromsø, Norway
Not Yet Recruiting
21
St. Olavs hospital HF
Trondheim, Norway
Actively Recruiting
22
Vestfold Hospital Trust
Tønsberg, Norway
Not Yet Recruiting
23
Volda hospital
Volda, Norway
Not Yet Recruiting
Research Team
T
Tobias S Slørdahl, MD PhD
CONTACT
J
Juni S Paulsen, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here